Literature DB >> 21602313

Leptin administration to overweight and obese subjects for 6 months increases free leptin concentrations but does not alter circulating hormones of the thyroid and IGF axes during weight loss induced by a mild hypocaloric diet.

Greeshma K Shetty1, Giuseppe Matarese, Faidon Magkos, Hyun-Seuk Moon, Xiaowen Liu, Aoife M Brennan, Geetha Mylvaganam, Despina Sykoutri, Alex M Depaoli, Christos S Mantzoros.   

Abstract

OBJECTIVE: Short-term energy deprivation reduces leptin concentrations and alters the levels of circulating hormones of the hypothalamic-pituitary-peripheral axis in lean subjects. Whether the reduction in leptin concentration during long-term weight loss in obese individuals is linked to the same neuroendocrine changes seen in lean, leptin-sensitive subjects remains to be fully clarified.
METHODS: In this study, 24 overweight and obese adults (16 women and eight men; body mass index (BMI): 27.5-38.0 kg/m(2)) were prescribed a hypocaloric diet (-500 kcal/day) and were randomized to receive recombinant methionyl leptin (n=18, metreleptin, 10 mg/day self-injected s.c.) or placebo (n=6, same volume and time as metreleptin) for 6 months.
RESULTS: Metreleptin administration did not affect weight loss beyond that induced by hypocaloric diet alone (P for interaction=0.341) but increased the serum concentrations of total leptin by six- to eight-fold (P<0.001) and led to the generation of anti-leptin antibodies. Despite free leptin concentration (P for interaction=0.041) increasing from 9±1 ng/ml at baseline to 43±15 and 36±12 ng/ml at 3 and 6 months, respectively, changes in circulating hormones of the thyroid and IGF axes at 3 and 6 months were not significantly different in the placebo- and metreleptin-treated groups.
CONCLUSIONS: Leptin does not likely mediate changes in neuroendocrine function in response to weight loss induced by a mild hypocaloric diet in overweight and obese subjects.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21602313      PMCID: PMC3159386          DOI: 10.1530/EJE-11-0252

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  28 in total

1.  Effects of recombinant leptin therapy in a child with congenital leptin deficiency.

Authors:  I S Farooqi; S A Jebb; G Langmack; E Lawrence; C H Cheetham; A M Prentice; I A Hughes; M A McCamish; S O'Rahilly
Journal:  N Engl J Med       Date:  1999-09-16       Impact factor: 91.245

2.  CSF leptin levels after exogenous administration of recombinant methionyl human leptin.

Authors:  K Fujioka; J Patane; J Lubina; D Lau
Journal:  JAMA       Date:  1999-10-27       Impact factor: 56.272

3.  Influences of obesity and weight loss on thyroid hormones. A 3-3.5-year follow-up study on obese subjects with surgical bilio-pancreatic by-pass.

Authors:  S Buscemi; S Verga; R Maneri; G Blunda; A Galluzzo
Journal:  J Endocrinol Invest       Date:  1997-05       Impact factor: 4.256

4.  Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.

Authors:  S B Heymsfield; A S Greenberg; K Fujioka; R M Dixon; R Kushner; T Hunt; J A Lubina; J Patane; B Self; P Hunt; M McCamish
Journal:  JAMA       Date:  1999-10-27       Impact factor: 56.272

5.  Role of leptin in the neuroendocrine response to fasting.

Authors:  R S Ahima; D Prabakaran; C Mantzoros; D Qu; B Lowell; E Maratos-Flier; J S Flier
Journal:  Nature       Date:  1996-07-18       Impact factor: 49.962

6.  The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men.

Authors:  Jean L Chan; Kathleen Heist; Alex M DePaoli; Johannes D Veldhuis; Christos S Mantzoros
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

7.  Leptin, thyrotropin, and thyroid hormones in obese/overweight women before and after two levels of energy deficit.

Authors:  Lucyna Kozłowska; Danuta Rosołowska-Huszcz
Journal:  Endocrine       Date:  2004-07       Impact factor: 3.633

8.  Recombinant human leptin in women with hypothalamic amenorrhea.

Authors:  Corrine K Welt; Jean L Chan; John Bullen; Robyn Murphy; Patricia Smith; Alex M DePaoli; Aspasia Karalis; Christos S Mantzoros
Journal:  N Engl J Med       Date:  2004-09-02       Impact factor: 91.245

9.  Changes in energy expenditure resulting from altered body weight.

Authors:  R L Leibel; M Rosenbaum; J Hirsch
Journal:  N Engl J Med       Date:  1995-03-09       Impact factor: 91.245

10.  Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin tolerance.

Authors:  Hyun-Seuk Moon; Giuseppe Matarese; Aoife M Brennan; John P Chamberland; Xiaowen Liu; Christina G Fiorenza; Geetha H Mylvaganam; Luisa Abanni; Fortunata Carbone; Catherine J Williams; Alex M De Paoli; Benjamin E Schneider; Christos S Mantzoros
Journal:  Diabetes       Date:  2011-06       Impact factor: 9.461

View more
  22 in total

Review 1.  Leptin applications in 2015: what have we learned about leptin and obesity?

Authors:  Olivia M Farr; Anna Gavrieli; Christos S Mantzoros
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2015-10       Impact factor: 3.243

Review 2.  20 years of leptin: role of leptin in energy homeostasis in humans.

Authors:  Michael Rosenbaum; Rudolph L Leibel
Journal:  J Endocrinol       Date:  2014-07-25       Impact factor: 4.286

Review 3.  Central regulation of hypothalamic-pituitary-thyroid axis under physiological and pathophysiological conditions.

Authors:  Csaba Fekete; Ronald M Lechan
Journal:  Endocr Rev       Date:  2013-12-13       Impact factor: 19.871

Review 4.  The role of leptin in health and disease.

Authors:  Angela M Ramos-Lobo; Jose Donato
Journal:  Temperature (Austin)       Date:  2017-05-26

Review 5.  Novel strategy for the use of leptin for obesity therapy.

Authors:  Charmaine S Tam; Virgile Lecoultre; Eric Ravussin
Journal:  Expert Opin Biol Ther       Date:  2011-09-13       Impact factor: 4.388

6.  Adipocyte versus pituitary leptin in the regulation of pituitary hormones: somatotropes develop normally in the absence of circulating leptin.

Authors:  Angela K Odle; Anessa Haney; Melody Allensworth-James; Noor Akhter; Gwen V Childs
Journal:  Endocrinology       Date:  2014-08-13       Impact factor: 4.736

Review 7.  GEOFFREY HARRIS PRIZE LECTURE 2018: Novel pathways regulating neuroendocrine function, energy homeostasis and metabolism in humans.

Authors:  Aimilia Eirini Papathanasiou; Eric Nolen-Doerr; Olivia M Farr; Christos S Mantzoros
Journal:  Eur J Endocrinol       Date:  2019-02-01       Impact factor: 6.664

Review 8.  Leptin revisited: its mechanism of action and potential for treating diabetes.

Authors:  Roberto Coppari; Christian Bjørbæk
Journal:  Nat Rev Drug Discov       Date:  2012-09       Impact factor: 84.694

Review 9.  Metreleptin: first global approval.

Authors:  Ken Chou; Caroline M Perry
Journal:  Drugs       Date:  2013-06       Impact factor: 9.546

10.  Metreleptin-mediated improvements in insulin sensitivity are independent of food intake in humans with lipodystrophy.

Authors:  Rebecca J Brown; Areli Valencia; Megan Startzell; Elaine Cochran; Peter J Walter; H Martin Garraffo; Hongyi Cai; Ahmed M Gharib; Ronald Ouwerkerk; Amber B Courville; Shanna Bernstein; Robert J Brychta; Kong Y Chen; Mary Walter; Sungyoung Auh; Phillip Gorden
Journal:  J Clin Invest       Date:  2018-07-16       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.